Vistagen Therapeutics Inc (VTGN)
4.50
+0.09
(+2.04%)
USD |
NASDAQ |
May 03, 16:00
4.49
-0.01
(-0.22%)
After-Hours: 20:00
Vistagen Therapeutics Cash and Short Term Investments (Quarterly): 126.56M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 126.56M |
| September 30, 2023 | 37.61M |
| June 30, 2023 | 9.622M |
| March 31, 2023 | 16.64M |
| December 31, 2022 | 25.04M |
| September 30, 2022 | 35.29M |
| June 30, 2022 | 51.99M |
| March 31, 2022 | 68.14M |
| December 31, 2021 | 83.70M |
| September 30, 2021 | 93.63M |
| June 30, 2021 | 97.78M |
| March 31, 2021 | 103.11M |
| December 31, 2020 | 104.33M |
| September 30, 2020 | 15.40M |
| June 30, 2020 | 1.546M |
| March 31, 2020 | 1.355M |
| December 31, 2019 | 1.063M |
| September 30, 2019 | 4.072M |
| June 30, 2019 | 8.297M |
| March 31, 2019 | 13.10M |
| December 31, 2018 | 6.285M |
| September 30, 2018 | 7.832M |
| June 30, 2018 | 7.231M |
| March 31, 2018 | 10.38M |
| December 31, 2017 | 13.03M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.764M |
| June 30, 2017 | 1.628M |
| March 31, 2017 | 2.921M |
| December 31, 2016 | 4.372M |
| September 30, 2016 | 6.257M |
| June 30, 2016 | 8.500M |
| March 31, 2016 | 0.4285M |
| December 31, 2015 | 1.158M |
| September 30, 2015 | 0.694M |
| June 30, 2015 | 0.121M |
| March 31, 2015 | 0.07M |
| December 31, 2014 | 0.0132M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.4007M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.0207M |
| September 30, 2013 | 0.0065M |
| June 30, 2013 | 0.0898M |
| March 31, 2013 | 0.6381M |
| December 31, 2012 | 0.0242M |
| September 30, 2012 | 0.0134M |
| June 30, 2012 | 0.0317M |
| March 31, 2012 | 0.081M |
| December 31, 2011 | 0.1664M |
| September 30, 2011 | 0.0945M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.063M
Minimum
Dec 2019
126.56M
Maximum
Dec 2023
46.59M
Average
35.29M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Ardelyx Inc | 184.30M |
| Axsome Therapeutics Inc | 386.19M |
| Vir Biotechnology Inc | 1.522B |
| Immuneering Corp | 85.67M |
| NovaBay Pharmaceuticals Inc | 3.13M |